Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Microvast Holdings (MVSTW) Cash & Equivalents (2019 - 2025)

Historic Cash & Equivalents for Microvast Holdings (MVSTW) over the last 7 years, with Q3 2025 value amounting to $90.7 million.

  • Microvast Holdings' Cash & Equivalents rose 4271.92% to $90.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.7 million, marking a year-over-year increase of 4271.92%. This contributed to the annual value of $73.0 million for FY2024, which is 6390.97% up from last year.
  • Per Microvast Holdings' latest filing, its Cash & Equivalents stood at $90.7 million for Q3 2025, which was up 4271.92% from $99.7 million recorded in Q2 2025.
  • Microvast Holdings' 5-year Cash & Equivalents high stood at $572.6 million for Q3 2021, and its period low was $9.6 million during Q1 2021.
  • Its 5-year average for Cash & Equivalents is $175.5 million, with a median of $90.9 million in 2025.
  • Per our database at Business Quant, Microvast Holdings' Cash & Equivalents skyrocketed by 22367504.04% in 2021 and then plummeted by 8075.32% in 2023.
  • Quarter analysis of 5 years shows Microvast Holdings' Cash & Equivalents stood at $480.9 million in 2021, then plummeted by 51.88% to $231.4 million in 2022, then crashed by 80.75% to $44.5 million in 2023, then soared by 63.91% to $73.0 million in 2024, then increased by 24.3% to $90.7 million in 2025.
  • Its Cash & Equivalents was $90.7 million in Q3 2025, compared to $99.7 million in Q2 2025 and $90.9 million in Q1 2025.